H.R. 5381: Opioid Treatment Providers Act
This bill, known as the Opioid Treatment Providers Act, aims to make opioid treatment programs eligible for certain federal grants. Specifically, it amends a section of the Social Security Act, allowing opioid treatment programs to receive health professions opportunity grants. Previously, eligibility for these grants was limited to certain organizations, and the bill expands this eligibility to include opioid treatment programs and other high-quality comprehensive addiction care providers.
Key Provisions
- The bill focuses on opioid treatment programs, which are facilities that provide medical care and support services to individuals dealing with opioid addiction.
- It allows these programs to access health professions opportunity grants, which are typically used to support workforce development in health care fields.
- The change enhances the ability of opioid treatment programs to receive funding, potentially improving their services and support for individuals in recovery.
- The amendment officially removes prior restrictions that excluded certain entities from grant eligibility.
Implementation Timeline
- The changes brought by this legislation will take effect on October 1, 2025.
- After this date, qualifying opioid treatment programs can begin to apply for the grants referenced in the amendment.
Goals of the Legislation
- Enhancing access to treatment for individuals with opioid use disorders.
- Supporting the development of a skilled workforce in addiction treatment and recovery services.
- Promoting comprehensive and effective care by expanding funding opportunities for treatment programs.
Relevant Companies
- PFE - Pfizer Inc.: As a major pharmaceutical company, Pfizer may be affected by increased demand for addiction treatment medications and therapies in programs that receive new funding.
- INDV - Indivior PLC: This company specializes in addiction treatment medications and could see an uptick in utilization of its products due to expanded treatment access through federally funded programs.
This is an AI-generated summary of the bill text. There may be mistakes.
Sponsors
1 sponsor
Actions
2 actions
| Date | Action |
|---|---|
| Sep. 16, 2025 | Introduced in House |
| Sep. 16, 2025 | Referred to the House Committee on Ways and Means. |
Corporate Lobbying
0 companies lobbying
None found.
* Note that there can be significant delays in lobbying disclosures, and our data may be incomplete.